Product ExpansionThe company announced a planned pivotal trial for Arakoda in treating babesiosis, which could lead to regulatory approval and expand the drug's market potential.
Research And DevelopmentNorth Carolina State University study will explore use of Arakoda for canine Babesiosis, potentially opening up a new market segment and diversifying the drug's applications.
Sales GrowthQ4 revenues from Arakoda were robust, surpassing estimates, signaling strong market acceptance and growing demand for the anti-malaria medicine.